PeptideStack
5.2kquestions
20kanswers
220users

Has anyone independently verified an ERP cagrilintide batch COA?

Asked 10 Mar 2026Modified 2 months agoViewed 12k times
22

The specifics, since they change the answer: ERP · cagrilintide.

This is asserted often enough that I assumed it was established, and then I went looking for the source.

I have searched the primary literature and found one paper that is adjacent but not on point.

Can anyone point me at a primary source, or confirm that there is not one?

vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
shareeditfollowflag
DB
askedDr_Signe_Baldursdottir29k2710 Mar 2026

5 Answers

Accepted answer first, then by votes
44

Accepted answer

Start with one request that costs nothing — a lot-specific certificate for the material you would actually be shipped — and read what comes back rather than whether something comes back.

The single most informative free test is asking for the certificate of the lot they intend to ship and then confirming, on arrival, that the code on the glass matches it. A supplier who can do that has a traceability system; one who cannot does not.

Set your accept threshold before you see the result. Deciding after the number arrives is how thresholds become negotiable, and everybody does it unless they wrote it down first.

Purity by RP-HPLC and quantified content are separate measurements answering separate questions, and only the second one tells you how many milligrams are in the vial.

Small first order, independent submission, then scale. In that order.

shareimprove this answerflag
TM
answered · acceptedtobias_maartens171k3588 Apr 2026
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
38

The short version: ask for the lot-specific certificate, check the method section, check the lot code ties to a vial, then spend a small amount and test it yourself.

Independent submission costs a fraction of a mid-sized order at any of the services this community uses, and it converts an opinion into a number attached to your own material.

The post-arrival sequence: inspect before reconstitution, photograph anything unexpected, confirm the lot code is physically on the vial, and submit a sample to an independent laboratory before committing to a larger order.

Match the code on the glass to the code on the certificate. Everything else is secondary.

shareimprove this answerflag
EV
answeredesther_vandeVelde52k2727 Mar 2026
16

This is the most answerable question on the site, because every step is cheap and every step is checkable.

Published third-party data on a named lot is worth more than any aggregate rating, because it is about a specific object rather than about an average of other people's objects.

The pre-order sequence: request a lot-specific certificate for the exact line, check that it names a lot code rather than a batch family, check that it carries the column, gradient and detection wavelength, and check the analysis date is recent relative to the lot.

Aggregate community ratings, including the one on this site, are opinion averages rather than measurements and should carry less weight than a single result on your own lot.

Write your accept threshold down before the result arrives.

edited 18 May 2026 by kwn_analytical — added the placebo-arm figures

shareimprove this answerflag
KA
answeredkwn_analytical147k35830 Apr 2026
8Worth flagging that comparing across laboratories is comparing laboratories, not suppliers. – void_volume 8 months ago
add a comment
12

Reputation is a prior. An independent result on your own vial is the evidence.

Repeat the exercise on a second lot months later. Lot-to-lot agreement is the property that actually predicts your next order, and it cannot be established from one submission.

Testing narrows uncertainty. It does not turn research-grade material into something with release testing behind it.

Two lots agreeing is worth more than one lot excelling.

edited 2 Jun 2026 by seven_day_half — updated for the 2026 guidance change

shareimprove this answerflag
SH
answeredseven_day_half31k13811 May 2026
4The cost-per-milligram-of-measured-content correction reversed my own spreadsheet. – rae_oyelowo 44 days ago
3Thank you — the checklist format makes this actionable rather than merely correct. – tobias_maartens 10 months ago
add a comment
-1

Answering this needs to know whether you have already ordered, because the pre-order checks and the post-arrival checks are different lists.

Ask what happens if a result comes back outside specification. The answer is informative regardless of what it is, and the question itself tells you something about how it lands.

Published inter-laboratory comparisons of peptide purity routinely find spreads of half a per cent to a per cent on identical material, which sets a realistic expectation for agreement.

Ask for the lot-specific certificate before ordering. It is free and it is decisive.

shareimprove this answerflag
IB
answeredilaria_bertone33k3819 Apr 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.